asp0113
Vaccineexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started May 1, 2013 (NCT01903928)
Timeline
Indications
Mechanism of action
- CytomegalovirusImmunity, active
Cytomegalovirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- asp0113
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02103426 | Phase 1 | Dec 1, 2013 | Astellas, Vical |
| NCT01974206 | Phase 2 | Nov 20, 2013 | Astellas, Vical |
| NCT01877655 | Phase 3 | Sep 22, 2013 | Astellas, Vical |
| NCT01903928 | Phase 2 | May 1, 2013 | Astellas |
Showing 4 of 4 trials
Page 1 / 1